IRADIMED Inc. (IRMD) Enterprise Value to EBITDA Ratio
IRADIMED CORPORATION (IRMD) creates exclusive monitoring systems for radiology centers by developing MRI-compatible devices. The trend of the base EV/EBITDA multiple visualizes the asset's market value, where the value 34.58 shows the current figure. Growth is supported by wholesale contracts with hospitals and IT synergy with scanner manufacturers, while the absence of global equivalents allows the company to exercise maximum pricing power.
Comprehensive metric breakdowns and analytics for iradimed.com (IRMD)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
IRMD - Net Financial Result|Projected Future Earnings IRADIMED CORPORATION|IRMD - Price to Earnings Ratio|Forward P/E Multiple IRADIMED CORPORATION|IRMD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IRADIMED Inc.|IRMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months IRADIMED|IRMD - Earnings per share for the trailing year|Quarterly EPS earnings growth iradimed.com|IRMD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year IRADIMED CORPORATION
Analysis of all company metrics:Iradimed IRMD
For IRADIMED CORPORATION (IRMD), which supplies specialized equipment to MRI centers, the multiple compares the total enterprise value with operating profit before depreciation, taxes, and interest. By analyzing the current EV/EBITDA valuation level, an investor determines the fundamental value of assets relative to cash flow, which allows for the identification of company undervaluation and an assessment of its ability to service debt loads within a capital-intensive production environment.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation EMBC|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|AxoGen Inc (AXGN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SIBN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|AMIX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|BBLG: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AXNX|EV/EBITDA Multiple Biolase Inc. (BIOL)|EV/EBITDA Multiple DYNT (Dynatronics)|FNA: Enterprise Value to Operating Income Before Depreciation|INVO Bio - EV/EBITDA Multiple
